Page 225 - HIV/AIDS Guidelines
P. 225
TCA tricyclic antidepressant
TDF tenofovir disoproxil fumarate
TDF/FTC tenofovir/emtricitabine
TDM therapeutic drug monitoring
TEN toxic epidermal necrosis
TG triglyceride
TID three times daily
TPV tipranavir
TPV/r tipranavir/ritonavir
TST tuberculin skin test
UDP uridine diphosphate
UGT uridine diphosphate gluconyltransferase
UGT1A1 uridine diphosphate glucuronosyltransferase 1A1
ULN upper limit of normal
VPA valproic acid
WBC white blood cell
WHO World Health Organization
WITS Women and Infants Transmission Study
XDR extensively drug-resistant
XR extended release
ZDV zidovudine
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents N-6
Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.
